The AHI is the most used biomarker of obstructive sleep apnea. It is used in most national and international guidelines, and leads in these guidelines to classify the severity of the disease from mild to moderate to severe. However, it also guides treatment indication.
This has been a very important parameter for years and years. However, at the moment we are very intensively discussing this aspect, this problem, because there’s more and more knowledge that the AHI does not really reflect patient related outcomes and does not really reflect comorbidities and consequences of the disease...
The AHI is the most used biomarker of obstructive sleep apnea. It is used in most national and international guidelines, and leads in these guidelines to classify the severity of the disease from mild to moderate to severe. However, it also guides treatment indication.
This has been a very important parameter for years and years. However, at the moment we are very intensively discussing this aspect, this problem, because there’s more and more knowledge that the AHI does not really reflect patient related outcomes and does not really reflect comorbidities and consequences of the disease. Therefore there’s a huge trend to leave… to change the parameter from AHI to others.